QNCX Annual Total Long Term Liabilities
$73.24 M
+$73.00 M+29433.87%
31 December 2023
Summary:
As of January 21, 2025, QNCX annual total long term liabilities is $73.24 million, with the most recent change of +$73.00 million (+29433.87%) on December 31, 2023. During the last 3 years, it has risen by +$73.04 million (+35113.46%). QNCX annual total long term liabilities is now -29.60% below its all-time high of $104.05 million, reached on December 31, 2018.QNCX Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
QNCX Quarterly Long Term Liabilities
$76.16 M
-$1.38 M-1.78%
30 September 2024
Summary:
As of January 21, 2025, QNCX quarterly total long term liabilities is $76.16 million, with the most recent change of -$1.38 million (-1.78%) on September 30, 2024. Over the past year, it has increased by +$2.92 million (+3.98%). QNCX quarterly long term liabilities is now -27.20% below its all-time high of $104.61 million, reached on March 31, 2019.QNCX Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
QNCX Long Term Liabilities Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +10000.0% | +4.0% |
3 y3 years | +10000.0% | +4.0% |
5 y5 years | -29.6% | +4.0% |
QNCX Long Term Liabilities High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | >+9999.0% | -1.8% | |
5 y | 5-year | at high | -1.8% | ||
alltime | all time | -29.6% | -27.2% |
Quince Therapeutics Long Term Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $76.16 M(-1.8%) |
June 2024 | - | $77.54 M(+3.0%) |
Mar 2024 | - | $75.28 M(+2.8%) |
Dec 2023 | $73.24 M(>+9900.0%) | $73.24 M(>+9900.0%) |
Sept 2023 | - | $0.00(0.0%) |
June 2023 | - | $0.00(0.0%) |
Mar 2023 | - | $0.00(-100.0%) |
Dec 2022 | $248.00 K(-41.0%) | $248.00 K(-17.6%) |
Sept 2022 | - | $301.00 K(-21.0%) |
June 2022 | - | $381.00 K(+852.5%) |
Mar 2022 | - | $40.00 K(-90.5%) |
Dec 2021 | $420.00 K | $420.00 K(-31.1%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2021 | - | $610.00 K(-21.1%) |
June 2021 | - | $773.00 K(+352.0%) |
Mar 2021 | - | $171.00 K(-17.8%) |
Dec 2020 | $208.00 K(>+9900.0%) | $208.00 K(-14.8%) |
Sept 2020 | - | $244.00 K(+388.0%) |
June 2020 | - | $50.00 K(-12.3%) |
Mar 2020 | - | $57.00 K(>+9900.0%) |
Dec 2019 | $0.00(-100.0%) | $0.00(0.0%) |
Sept 2019 | - | $0.00(0.0%) |
June 2019 | - | $0.00(-100.0%) |
Mar 2019 | - | $104.61 M(+0.5%) |
Dec 2018 | $104.05 M(+296.6%) | $104.05 M |
Dec 2017 | $26.23 M | - |
FAQ
- What is Quince Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Quince Therapeutics?
- What is Quince Therapeutics annual total long term liabilities year-on-year change?
- What is Quince Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Quince Therapeutics?
- What is Quince Therapeutics quarterly long term liabilities year-on-year change?
What is Quince Therapeutics annual total long term liabilities?
The current annual total long term liabilities of QNCX is $73.24 M
What is the all time high annual total long term liabilities for Quince Therapeutics?
Quince Therapeutics all-time high annual total long term liabilities is $104.05 M
What is Quince Therapeutics annual total long term liabilities year-on-year change?
Over the past year, QNCX annual total long term liabilities has changed by +$73.00 M (+29433.87%)
What is Quince Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of QNCX is $76.16 M
What is the all time high quarterly long term liabilities for Quince Therapeutics?
Quince Therapeutics all-time high quarterly total long term liabilities is $104.61 M
What is Quince Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, QNCX quarterly total long term liabilities has changed by +$2.92 M (+3.98%)